Danazol Capsule
NDC Package 71205-862-72
Package Information
Danazol capsules is a medication used in women to treat pelvic pain and infertility due to a certain uterus disorder (endometriosis) and also to treat breast pain/tenderness/nodules due to a certain breast condition (fibrocystic breast disease). This formulation utilizes a capsule delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 71205-862 and is authorized under FDA application ANDA077246.
Identification & Billing
- RxCUI: 197554 - danazol 100 MG Oral Capsule
- RxCUI: 197555 - danazol 200 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71205 - Proficient Rx Lp
- 71205-862 - Danazol
- 71205-862-72 - 120 CAPSULE in 1 BOTTLE
- 71205-862 - Danazol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71205-862). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71205-862-72 identifies a specific commercial package of 120 capsule in 1 bottle of Danazol, a human prescription drug labeled by Proficient Rx Lp. This product is billed for "EA" each discreet unit and contains an estimated amount of 120 billable units per package. This capsule is formulated for oral use and contains danazol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on September 28, 2005. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used in women to treat pelvic pain and infertility due to a certain uterus disorder (endometriosis) and also to treat breast pain/tenderness/nodules due to a certain breast condition (fibrocystic breast disease). It is also used in both men and women to prevent swelling of the abdomen/arms/legs/face/airway due to a certain congenital disease (hereditary angioedema). Danazol is an androgen similar to testosterone. For the treatment of endometriosis and fibrocystic breast disease, it works by decreasing the amount of hormones made by the ovaries. These hormones usually make the conditions worse. For the treatment of angioedema, danazol helps to increase the amount of a certain protein in your body's defense system (immune system).
How is this Proficient Rx Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71205086272. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.